Gut microbiome and plasma metabolome changes in rats after oral gavage of nanoparticles: sensitive indicators of possible adverse health effects.

Gut microbiota Intestinal microbiome Metabolomics Nanomaterial Oral nanoparticle administration SiO2 nanoparticles Silver nanoparticles

Journal

Particle and fibre toxicology
ISSN: 1743-8977
Titre abrégé: Part Fibre Toxicol
Pays: England
ID NLM: 101236354

Informations de publication

Date de publication:
23 03 2022
Historique:
received: 30 11 2021
accepted: 01 03 2022
entrez: 24 3 2022
pubmed: 25 3 2022
medline: 15 4 2022
Statut: epublish

Résumé

The oral uptake of nanoparticles is an important route of human exposure and requires solid models for hazard assessment. While the systemic availability is generally low, ingestion may not only affect gastrointestinal tissues but also intestinal microbes. The gut microbiota contributes essentially to human health, whereas gut microbial dysbiosis is known to promote several intestinal and extra-intestinal diseases. Gut microbiota-derived metabolites, which are found in the blood stream, serve as key molecular mediators of host metabolism and immunity. Gut microbiota and the plasma metabolome were analyzed in male Wistar rats receiving either SiO The combined profiling of intestinal microbiome and plasma metabolome may serve as an early and sensitive indicator of gut microbiome changes induced by orally administered nanoparticles; this will help to recognize potential adverse effects of these changes to the host.

Sections du résumé

BACKGROUND
The oral uptake of nanoparticles is an important route of human exposure and requires solid models for hazard assessment. While the systemic availability is generally low, ingestion may not only affect gastrointestinal tissues but also intestinal microbes. The gut microbiota contributes essentially to human health, whereas gut microbial dysbiosis is known to promote several intestinal and extra-intestinal diseases. Gut microbiota-derived metabolites, which are found in the blood stream, serve as key molecular mediators of host metabolism and immunity.
RESULTS
Gut microbiota and the plasma metabolome were analyzed in male Wistar rats receiving either SiO
CONCLUSIONS
The combined profiling of intestinal microbiome and plasma metabolome may serve as an early and sensitive indicator of gut microbiome changes induced by orally administered nanoparticles; this will help to recognize potential adverse effects of these changes to the host.

Identifiants

pubmed: 35321750
doi: 10.1186/s12989-022-00459-w
pii: 10.1186/s12989-022-00459-w
pmc: PMC8941749
doi:

Substances chimiques

Silver 3M4G523W1G
Silicon Dioxide 7631-86-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

21

Informations de copyright

© 2022. The Author(s).

Références

Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3698-703
pubmed: 19234110
Food Chem Toxicol. 2016 Jun;92:177-87
pubmed: 27090107
Nature. 2015 Feb 26;518(7540):S3-11
pubmed: 25715278
Elife. 2013 Nov 05;2:e01202
pubmed: 24192039
Nutrients. 2016 Apr 06;8(4):202
pubmed: 27058556
Metabolites. 2020 Dec 08;10(12):
pubmed: 33302528
Microb Ecol. 2016 Nov;72(4):741-758
pubmed: 26748500
Biotechnol Lett. 2008 Nov;30(11):1893-9
pubmed: 18604478
Toxicol Lett. 2007 Jul 30;172(1-2):21-8
pubmed: 17614222
Environ Sci Technol. 2018 Aug 7;52(15):8792-8800
pubmed: 29969018
Nat Commun. 2018 Aug 17;9(1):3294
pubmed: 30120222
Sci Rep. 2019 Oct 1;9(1):14026
pubmed: 31575902
Front Genet. 2015 Apr 20;6:148
pubmed: 25941533
Gut. 2016 Mar;65(3):426-36
pubmed: 26100928
Curr Environ Health Rep. 2016 Sep;3(3):270-86
pubmed: 27436048
Mutat Res. 2012 Aug 15;746(2):144-50
pubmed: 22305969
BMC Microbiol. 2009 Jun 09;9:123
pubmed: 19508720
Nat Rev Gastroenterol Hepatol. 2020 Apr;17(4):223-237
pubmed: 32076145
Part Fibre Toxicol. 2014 Feb 07;11:8
pubmed: 24507464
Sci Rep. 2018 Jan 25;8(1):1565
pubmed: 29371617
Immunity. 2018 Aug 21;49(2):353-362.e5
pubmed: 30119997
Nanomedicine (Lond). 2014 Nov;9(16):2557-85
pubmed: 25490426
Nanoscale Res Lett. 2014 Sep 26;9(1):532
pubmed: 25288919
Toxicol Lett. 2018 Oct 15;296:139-151
pubmed: 30102961
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Physiol Genomics. 2018 Apr 1;50(4):244-254
pubmed: 29373083
Nanotoxicology. 2013 Aug;7(5):953-60
pubmed: 22417112
Life Sci. 2016 Nov 15;165:91-99
pubmed: 27686832
Arch Toxicol. 2017 Oct;91(10):3439-3454
pubmed: 28337503
Nat Rev Neurosci. 2012 Oct;13(10):701-12
pubmed: 22968153
Int J Nanomedicine. 2014 Dec 15;9 Suppl 2:67-78
pubmed: 25565827
Health Phys. 1968 Dec;15(6):505-14
pubmed: 4972147
Trends Cogn Sci. 2018 Jul;22(7):611-636
pubmed: 29907531
J Appl Toxicol. 2012 Nov;32(11):929-33
pubmed: 22610381
J Toxicol Environ Health A. 1998 Jan 9;53(1):47-60
pubmed: 9447228
Nat Med. 2016 Jun;22(6):598-605
pubmed: 27158904
J Phys Chem C Nanomater Interfaces. 2015 Sep 3;119(35):20632-20641
pubmed: 28373899
Environ Sci Pollut Res Int. 2015 Jan;22(2):1127-32
pubmed: 25113834
Arch Toxicol. 2012 Apr;86(4):543-51
pubmed: 21969074
Arch Toxicol. 2012 Nov;86(11):1641-6
pubmed: 23052193
J Vet Med Sci. 2011 Nov;73(11):1417-23
pubmed: 21712637
Nanotoxicology. 2016;10(5):513-20
pubmed: 26525505
Nanoscale. 2017 May 18;9(19):6315-6326
pubmed: 28275767
Toxicol Lett. 2019 Sep 15;312:72-97
pubmed: 31034867
Nat Microbiol. 2019 Feb;4(2):293-305
pubmed: 30531976
Regul Toxicol Pharmacol. 2014 Feb;68(1):1-7
pubmed: 24231525
Cell Rep. 2018 Apr 24;23(4):1099-1111
pubmed: 29694888
J Appl Toxicol. 2019 Jan;39(1):27-37
pubmed: 30247756
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
Crit Rev Toxicol. 2014 Nov;44(10):849-75
pubmed: 25257841
Nature. 2020 Jan;577(7792):S10-S11
pubmed: 31996826
Sci Rep. 2019 Nov 28;9(1):17860
pubmed: 31780788
Proc Natl Acad Sci U S A. 2020 Aug 11;117(32):19376-19387
pubmed: 32719140
Environ Mol Mutagen. 2015 Mar;56(2):218-27
pubmed: 25504566
Arch Toxicol. 2014 Oct;88(10):1881-906
pubmed: 25164825
Regul Toxicol Pharmacol. 2016 Nov;81:288-304
pubmed: 27637788
Best Pract Res Clin Gastroenterol. 2017 Dec;31(6):637-642
pubmed: 29566906
Curr Opin Microbiol. 2017 Feb;35:8-15
pubmed: 27883933
Toxicol Mech Methods. 2013 Mar;23(3):161-7
pubmed: 23301827
Nanotoxicology. 2015 May;9(3):279-89
pubmed: 24877679
Gut Microbes. 2020 Nov 9;12(1):1805281
pubmed: 32865119
Brain Res. 2018 Aug 15;1693(Pt B):128-133
pubmed: 29903615
Part Fibre Toxicol. 2016 Jul 08;13(1):38
pubmed: 27393559
Cell Mol Life Sci. 2019 Oct;76(20):3917-3937
pubmed: 31250035
Environ Toxicol Pharmacol. 2010 Sep;30(2):162-8
pubmed: 21787647
Part Fibre Toxicol. 2019 Nov 7;16(1):41
pubmed: 31699096
Nat Microbiol. 2019 Dec;4(12):2064-2073
pubmed: 31477894
Toxicol Lett. 2012 Nov 30;215(2):143-9
pubmed: 23103988
Front Cell Infect Microbiol. 2018 Feb 06;8:13
pubmed: 29468141
Toxicol Lett. 2014 Nov 4;230(3):467-78
pubmed: 25086301
Nature. 2020 Mar;579(7800):567-574
pubmed: 32214244
Nature. 2020 Jan;577(7792):S16-S18
pubmed: 31996833
Biomaterials. 2013 Mar;34(10):2565-75
pubmed: 23332175
Trends Biotechnol. 2010 Nov;28(11):580-8
pubmed: 20724010
Microb Pathog. 2017 May;106:171-181
pubmed: 26875998
Trans Am Clin Climatol Assoc. 2020;131:178-197
pubmed: 32675857
Part Fibre Toxicol. 2011 Jun 01;8:18
pubmed: 21631937
Environ Sci Technol. 2014 Oct 21;48(20):11954-61
pubmed: 25265014
Part Fibre Toxicol. 2020 Jun 1;17(1):19
pubmed: 32487227
Cell Metab. 2015 Oct 6;22(4):658-68
pubmed: 26321659
Front Microbiol. 2018 Aug 03;9:1791
pubmed: 30123208
Curr Opin Gastroenterol. 2005 Jul;21(4):414-8
pubmed: 15930980
Int J Nanomedicine. 2014 Dec 15;9 Suppl 2:251-60
pubmed: 25565843
Microbiome. 2018 May 17;6(1):90
pubmed: 29773078
Microb Biotechnol. 2019 Nov;12(6):1109-1125
pubmed: 31006995
Regul Toxicol Pharmacol. 2018 Oct;98:257-267
pubmed: 30125612
ACS Nano. 2012 Aug 28;6(8):7427-42
pubmed: 22857815
Nat Metab. 2019 Jan;1(1):34-46
pubmed: 32694818
Inhal Toxicol. 2008 Apr;20(6):575-83
pubmed: 18444010
Int J Food Microbiol. 2011 Dec 2;151(2):125-40
pubmed: 21962867
J Leukoc Biol. 2017 Apr;101(4):811-821
pubmed: 27418353
Med Hypotheses. 2016 Sep;94:103-7
pubmed: 27515213
Therap Adv Gastroenterol. 2013 Jul;6(4):295-308
pubmed: 23814609
Sci Transl Med. 2020 Jul 8;12(551):
pubmed: 32641487
Nat Biotechnol. 2019 Aug;37(8):852-857
pubmed: 31341288
Arch Toxicol. 2010 Jan;84(1):63-9
pubmed: 19756516

Auteurs

Robert Landsiedel (R)

Experimental Toxicology and Ecology, BASF SE, 67056, Ludwigshafen am Rhein, Germany.
Institute of Pharmacy, Pharmacology and Toxicology, Freie Universität Berlin, 14195, Berlin, Germany.

Daniela Hahn (D)

Biomedical Technology Center of the Medical Faculty, University of Muenster, Mendelstrasse 17, 48149, Muenster, Germany.

Rainer Ossig (R)

Biomedical Technology Center of the Medical Faculty, University of Muenster, Mendelstrasse 17, 48149, Muenster, Germany.

Sabrina Ritz (S)

Biomedical Technology Center of the Medical Faculty, University of Muenster, Mendelstrasse 17, 48149, Muenster, Germany.

Lydia Sauer (L)

Biomedical Technology Center of the Medical Faculty, University of Muenster, Mendelstrasse 17, 48149, Muenster, Germany.

Roland Buesen (R)

Experimental Toxicology and Ecology, BASF SE, 67056, Ludwigshafen am Rhein, Germany.

Sascha Rehm (S)

HB Technologies AG, 72076, Tübingen, Germany.
Medical Data Integration Center, University Tuebingen, 72072, Tübingen, Germany.

Wendel Wohlleben (W)

Polymer Physics, BASF SE, 67056, Ludwigshafen am Rhein, Germany.

Sibylle Groeters (S)

Experimental Toxicology and Ecology, BASF SE, 67056, Ludwigshafen am Rhein, Germany.

Volker Strauss (V)

Experimental Toxicology and Ecology, BASF SE, 67056, Ludwigshafen am Rhein, Germany.

Saskia Sperber (S)

Experimental Toxicology and Ecology, BASF SE, 67056, Ludwigshafen am Rhein, Germany.

Haleluya Wami (H)

Institute of Hygiene, University of Muenster, 48149, Muenster, Germany.

Ulrich Dobrindt (U)

Institute of Hygiene, University of Muenster, 48149, Muenster, Germany.

Karola Prior (K)

Department of Periodontology and Operative Dentistry, University Hospital Muenster, 48149, Muenster, Germany.

Dag Harmsen (D)

Department of Periodontology and Operative Dentistry, University Hospital Muenster, 48149, Muenster, Germany.

Bennard van Ravenzwaay (B)

Experimental Toxicology and Ecology, BASF SE, 67056, Ludwigshafen am Rhein, Germany.

Juergen Schnekenburger (J)

Biomedical Technology Center of the Medical Faculty, University of Muenster, Mendelstrasse 17, 48149, Muenster, Germany. schnekenburger@uni-muenster.de.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH